Navigation Links
New tests for determining health and environmental effects of nanomaterials

A group of international experts from government, industry and academia have concluded that alternative testing strategies (ATSs) that don't rely on animals will be needed to cope with the wave of new nanomaterials emerging from the boom in nanoscience and nanotechnology. Their consensus statement from a workshop on the topic appears in the journal ACS Nano.

Andre Nel and colleagues explain that many new engineered nanomaterials (ENMs) are appearing in laboratories, factories and consumer products as a result of advances in nanoscience and nanotechnology. These fields involve materials so small that hundreds would fit inside the period at the end of this sentence, and they have properties much different from larger particles of the same material. Tests on laboratory mice, rats and other animals have been the standard way of checking new materials for health and environmental effects. Since those tests are costly, labor-intensive and time-consuming, workshop participants considered whether ATSs could have a larger role in checking the safety of ENMs.

They concluded that rapid cellular screening, computer modeling and other ATSs could serve as quick, cost-effective and reliable approaches for gathering certain types of information about the health and environmental effects of ENMs. "After lively discussions, a short list of generally shared viewpoints on this topic was generated, including a general view that ATS approaches for ENMs can significantly benefit chemical safety analysis," they say.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related biology news :

1. First human tests of new biosensor that warns when athletes are about to hit the wall
2. H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance
3. People can beat guilt detection tests by suppressing incriminating memories
4. Tests lead to doubling of fuel cell life
5. Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study
6. Novel screening tests for liver cancer
7. First tests of old patent medicine remedies from a museum collection
8. Rapid, point-of-care tests for syphilis: The future of diagnosis
9. Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
10. Clinical trial tests rice bran to prevent cancer
11. UF researcher tests powerful new tool to advance ecology, conservation
Post Your Comments:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology: